Enlarged perivascular spaces and plasma Aβ42/Aβ40 ratio in older adults without dementia
Name:
1-s2.0-S0197458023000726-main.pdf
Size:
1.633Mb
Format:
PDF
Description:
Final Published Version
Author
Kapoor, A.Gaubert, A.
Yew, B.
Jang, J.Y.
Dutt, S.
Li, Y.
Alitin, J.P.M.
Nguyen, A.
Ho, J.K.
Blanken, A.E.
Sible, I.J.
Marshall, A.
Shenasa, F.
Rodgers, K.E.
Martini, A.C.
Head, E.
Nation, D.A.
Affiliation
Department of Pharmacology, University of ArizonaIssue Date
2023-08Keywords
Alzheimer's diseaseAβ42/Aβ40 Ratio
Perivascular spaces
Small vessel disease
Vascular cognitive impairment
Metadata
Show full item recordPublisher
Elsevier Inc.Citation
Kapoor, A., Gaubert, A., Yew, B., Jang, J. Y., Dutt, S., Li, Y., ... & Nation, D. A. (2023). Enlarged perivascular spaces and plasma Aβ42/Aβ40 ratio in older adults without dementia. Neurobiology of aging, 128, 43-48.Journal
Neurobiology of AgingRights
© 2023 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/).Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Dilation of perivascular spaces (PVS) in the brain may indicate poor fluid drainage due to the accumulation of perivascular cell debris, waste, and proteins, including amyloid-beta (Aβ). No prior study has assessed whether plasma Aβ levels are related to PVS in older adults without dementia. Independently living older adults (N = 56, mean age = 68.2 years; Standard deviation (SD) = 6.5; 30.4% male) free of dementia or clinical stroke were recruited from the community and underwent brain MRI and venipuncture. PVS were qualitatively scored and dichotomized to low PVS burden (scores 0–1,) or high PVS burden (score>1). Plasma was assayed using a Quanterix Simoa Kit to quantify Aβ42 and Aβ40 levels. A significant difference was observed in plasma Aβ42/Aβ40 ratio between low and high PVS burden, controlling for age (F[1, 53] = 5.59, p = 0.022, η2 = 0.10), with lower Aβ42/Aβ40 ratio in the high PVS burden group. Dilation of PVS is associated with a lower plasma Aβ42/Aβ40 ratio, which may indicate higher cortical amyloid deposition. Future longitudinal studies examining PVS changes, and the pathogenesis of AD are warranted. © 2023 The AuthorsNote
Open access articleISSN
0197-4580PubMed ID
37156179Version
Final Published Versionae974a485f413a2113503eed53cd6c53
10.1016/j.neurobiolaging.2023.04.004
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © 2023 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/).
Related articles
- Association of β-Amyloid, Microglial Activation, Cortical Thickness, and Metabolism in Older Adults Without Dementia.
- Authors: Cai Y, Shi D, Lan G, Chen L, Jiang Y, Zhou L, Guo T, Alzheimer's Disease Neuroimaging Initiative
- Issue date: 2024 Apr 9
- Blood Derived Amyloid Biomarkers for Alzheimer's Disease Prevention.
- Authors: Udeh-Momoh C, Zheng B, Sandebring-Matton A, Novak G, Kivipelto M, Jönsson L, Middleton L
- Issue date: 2022
- Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer's disease in individuals with subjective cognitive decline.
- Authors: Pascual-Lucas M, Allué JA, Sarasa L, Fandos N, Castillo S, Terencio J, Sarasa M, Tartari JP, Sanabria Á, Tárraga L, Ruíz A, Marquié M, Seo SW, Jang H, Boada M, FACEHBI study group
- Issue date: 2023 Jan 5
- A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's disease.
- Authors: Shahpasand-Kroner H, Klafki HW, Bauer C, Schuchhardt J, Hüttenrauch M, Stazi M, Bouter C, Wirths O, Vogelgsang J, Wiltfang J
- Issue date: 2018 Dec 8
- Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the App(NL-F/NL-F) knock-in mouse model of Alzheimer's disease.
- Authors: Andersson E, Schultz N, Saito T, Saido TC, Blennow K, Gouras GK, Zetterberg H, Hansson O
- Issue date: 2023 Mar 25